Abstract:Human milk oligosaccharides (HMOs) are essentially unaffected by the digestive enzymes of the nursling and are known for their ability to enrich certain microbial species in the infant gut microbiota, in particular bifidobacteria. HMO metabolism has been studied in various bifidobacterial species such as B. breve, B. bifidum, and B. longum subsp. infantis. In the current study, we describe differential growth abilities elicited by twenty-three newly isolated Bifidobacterium pseudocatenulatum strains on particular HMOs, such as 2'-fucosyllactose (2'FL), 3-fucosyllactose (3FL), lacto-N-tetraose (LNT), and lacto-N-neotetraose (LNnT). Through gene-trait matching and comparative genome analysis, we identified genes involved in the degradation of fucosylated HMOs in this strain set, while we employed a transcriptomic approach to facilitate the identification and characterization of genes and associated enzymes involved in LNT metabolism by strain B. pseudocatenulatum MM0196. A total of 252 publicly available genomes of the B. pseudocatenulatum taxon were screened for homologs of the glycosyl hydrolases (GHs) identified here as being required for selected HMO metabolism. From this analysis, it is clear that all members of this species possess homologs of the genes involved in LNT degradation, while genes required for degradation of fucosylated HMOs are variably present.IMPORTANCEOur findings allow a better understanding of the complex interaction between Bifidobacterium and its host and provide a roadmap toward future applications of B. pseudocatenulatum as a probiotic with a focus on infant health. Furthermore, our investigations have generated information on the role of HMOs in shaping the infant gut microbiota, thus also facilitating applications of HMOs in infant nutrition, with potential extension into the mature or adult gut microbiota. Supplementation of HMOs is known to result in the modulation of bacterial communities toward a higher relative abundance of bifidobacteria, which in turn enforces their ability to modulate particular immune functions and strengthen the intestinal barrier. This work may therefore inspire future studies to improve the formulation of neonatal nutritional products, aimed at facilitating the development of a healthy digestive and immune system and reducing the differences in gut microbiota composition observed between breastfed and formula-fed babies or full-term and preterm infants.

The Enzymatic Hydrolysis of Human Milk Oligosaccharides and Prebiotic Sugars from LAB Isolated from Breast Milk

Enzymatic production of a suite of human milk oligosaccharides directly in milk

Molecular strategies for the utilisation of human milk oligosaccharides by infant gut-associated bacteria

In Vitro Fermentation of Human Milk Oligosaccharides by Individual Bifidobacterium Longum-Dominant Infant Fecal Inocula.

An In Vitro Colonic Fermentation Study of the Effects of Human Milk Oligosaccharides on Gut Microbiota and Short-Chain Fatty Acid Production in Infants Aged 0-6 Months

Bifidobacterial enzymes involved in the metabolism of human milk oligosaccharides

Production of human milk oligosaccharides by enzymatic and whole-cell microbial biotransformations

Isolation and Characterisation of Streptococcus Spp. with Human Milk Oligosaccharides Utilization Capacity from Human Milk

Selective human milk oligosaccharide utilization by members of the Bifidobacterium pseudocatenulatum taxon

Breast milk-derived human milk oligosaccharides promote Bifidobacterium interactions within a single ecosystem

Oligosaccharides in human milk: structural, functional, and metabolic aspects

Beneficial effects of human milk oligosaccharides on gut microbiota

Oligosaccharides and Microbiota in Human Milk Are Interrelated at 3 Months Postpartum in a Cohort of Women with a High Prevalence of Gestational Impaired Glucose Tolerance

Modifiable and Non-Modifiable Factors That Affect Human Milk Oligosaccharides Composition

In Love with Shaping You-Influential Factors on the Breast Milk Content of Human Milk Oligosaccharides and Their Decisive Roles for Neonatal Development

Background for development of a new infant formula for healthy infant containing prebiotic oligosaccharides scGOS/lcFOS, 3'GL and postbiotics

Linking human milk oligosaccharide metabolism and early life gut microbiota: bifidobacteria and beyond

Enzymatic and Chemoenzymatic Synthesis of Human Milk Oligosaccharides and Derivatives.

Human Milk Oligosaccharides and Immune System Development

Human Milk Oligosaccharides: Their Effects on the Host and Their Potential as Therapeutic Agents

In Vitro Infant Fecal Fermentation Characteristics of Human Milk Oligosaccharides Were Controlled by Initial Microbiota Composition More Than Chemical Structure.